1Merritt MA, Cramer DW. Molecular pathogenesis of endometrial and ovarian cancer [ J ]. Cancer Biomark, 2010, 9 (1-6) : 287-305.
2Dorigo O, Berek JS. Personalizing CA125 levels for ovarian cancer screening[J]. Cancer Prey Res(Phila), 2011,4(9) : 1356-1359.
3Nakae M, Iwamoto I, Fujino T, et al. Preoperative plasma osteopon- tin level as a biomarker complementary to carbohydrate antigen 125 in predicting ovarian cancer [ J ]. Journal of Obstetrics and Gynaecology Research, 2006, 32(3): 309-314.
4Elg SA, Carson LF, Fowler JM, et al. Ascites levels of haptoglo- bin in patients with ovarian cancer[ J]. Cancer, 1993, 71 ( 12 ) : 3938-3941.
5Zhao C, Annamalai L, Guo C, et al. Circulating haptoglobin is an in- dependent prognostic factor in the sera of patients with epithelial ovari- an cancer[J]. Neoplasia, 2007, 9( 1 ) : 1-7.
6Schummer M, Ng WV, Bumgarner RE, et al. Comparative hy- bridization of an array of 21 , 500 ovarian cDNAs for the discovery of genes overexpressed in ovarian carcinomas [ J]. Gene, 1999, 238(2) : 375-385.
7Moore RG, Brown AK, Miller MC, et al. The use of multiple no- vel tumor biomarkers for the detection of ovarian carcinoma in pa-tients with a pelvic mass[ J]. Gynecologic Oncology, 2008, 108 (2) : 402-408.
8Holcomb K, Vucetic Z, Miller MC, et al. Human epididymis protein 4 offers superior specificity in the differentiation of benign and malig- nant adnexal masses in premenopausal women[ J]. Am J Obstet Gyne- col, 2011, 205(358): e351-e356.
9Scholler N, Crawford M, Sato A, et al. Bead-based ELISA for valida- tion of ovarian cancer early detection markers [ J ]. Clinical Cancer Re- search, 2006, 12(7): 2117-2124.
10McIntosh MW, Drescher C, Karlan B, et al. Combining CA125 and SMR serum markers for diagnosis and early detection of ovarian carci- noma [ J ]. Gynecologic Oncology, 2004, 95 ( 1 ) : 9-15.
同被引文献14
1Kalogera E,Scholler N,Powless C,et al.Correlation of serum HE4 with tumor size and myometrial invasion in endometrial cancer[J].Gynecologic Oncology,2012,124(2):270.
2Bionotti E,Ragnoli M,Zanotti L,et al.Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients[J].Br J Cancer,2011,104(9):1418.
